This article is more than 5 years old. Information may no longer be current.

FDA approves aspheric IOL from Rayner

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

HOVE, U.K. — The U.S. Food and Drug Administration has approved the C-flex aspheric 970C IOL from Rayner Intraocular Lenses Limited, the company announced in a press release.

The IOL is manufactured with hydrophilic acrylic material and has an enhanced square edge for reduced posterior capsular opacification. It also incorporates anti-vaulting haptic technology, which allows for improved fixation within the capsular bag, strong centration of the lens, and reduced twisting or buckling, according to Rayner's website.

The IOL will be available in 0.5 D increments from +18 D to +30 D.

Earlier this month, Rayner earned CE mark approval for its Sulcoflex multifocal toric IOL, according to the company website.

Rayner expects to release the device to the European market in the first quarter of 2012.